Every day begins with scream therapy at Camp Breastie for breast cancer survivors. (New York Times)
Comedian and actor Moshe Kasher, who appeared as a sign language interpreter in episodes of “The Pitt,” revealed he had surgery for early oropharyngeal cancer. (USA Today)
Tennis legend Chris Evert announced she will be unable to attend Wimbledon because of a recurrence of ovarian cancer. (ESPN)
In a randomized trial, the investigational antibody-drug conjugate sigvotatug vedotin failed to improve survival in non-small cell lung cancer in the overall population but had a positive effect in patients who had received no more than one prior therapy, Pfizer announced.
The FDA granted full approval and expanded indications for the genetically modified T-cell immunotherapy afamitresgene autoleucel (Tecelra) to include patients ages 12 and older with previously treated unresectable or metastatic synovial sarcoma, US WorldMeds said.
In an untitled letter, the FDA accused Pinnacle Biologics of producing “false or misleading” videos that make it difficult for healthcare providers to “adequately process and comprehend the full indications” for the company’s photodynamic therapy Photofrin. (Fierce Pharma)
Pigeons trained to watch videos of CT scans developed the ability to recognize suspicious nodules in the human body. (Popular Science)
In a preclinical model of neuroblastoma, combining a radiopharmaceutical with CAR T-cell therapy led to significant tumor regression, a possible clue to making CAR T-cell therapy more effective in solid tumors. (Cell Reports Medicine)
Thirteen of 15 patients with skin adverse events associated with cancer treatment had rapid improvement in skin status with the interleukin-31 inhibitor nemolizumab (Nemluvio), currently approved for atopic dermatitis and prurigo nodularis. (Journal of the American Academy of Dermatology)
Shortages of widely used generic chemotherapy drugs have sparked talk of drug rationing within the oncology community. (New York Times)
The FDA has reached out to Indian pharmaceutical manufacturers for help in relieving the critical shortage of the cancer drug ifosfamide. (NDTV)
Cancer mortality continues to decline, but Black and Native American patients are not seeing the benefits. (NBC News)
A man’s unexplained double vision turned out to be a symptom of advanced kidney cancer. (CBS News)
Accelerated immune system aging may help explain the recent increase in multiple cancers in younger patients. (WashU Medicine)
PET-CT imaging with a gallium-based tracer showed promise for diagnosing prostate cancer in patients with equivocal or high-risk non-suspicious findings on MRI. (Lancet Oncology)
Use of GLP-1 agonists was associated with a lower risk of colorectal cancer in patients with inflammatory bowel disease. (American Society of Clinical Oncology Breakthrough Meeting)
Susan G. Komen announced $15.4 million in grants to support research to accelerate breakthroughs in breast cancer.
Changes in artificial intelligence-informed risk scores may have the potential to identify developing breast cancers years before diagnosis. (Breast Cancer Research Foundation)
Source link : https://www.medpagetoday.com/hematologyoncology/breastcancer/121953
Author :
Publish date : 2026-06-26 18:19:00
Copyright for syndicated content belongs to the linked Source.
